The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
From diffusive haemodialysis to online haemodiafiltration
EuDial Working Group
Speaker
Björn Meijers, Belgium
Panellists
Gaetano Alfano, Italy
Yuri Battaglia, Italy
Moderator
Rukshana Shroff, United Kingdom